Pfizer (PFE) Sells Off on Ibrance Miss, Cantor Fitzgerald Believes Miss Isn't Enough to Derail 2020 Ests

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. USO
6. AWK
7. GNK
8. ARGX
9. FNGR
10. PLUR

Go back to Pfizer (PFE) Sells Off on Ibrance Miss, Cantor Fitzgerald Believes Miss Isn't Enough to Derail 2020 Ests

Pfizer (PFE) PT Lowered to $39 at Wolfe Research

June 1, 2020 8:36 AM EDT

Wolfe Research analyst Tim Anderson lowered the price target on Pfizer (NYSE: PFE) to $39.00 (from $41.00) while maintaining a Peerperform rating.

The analyst comments "We lower our peak estimate for Ibrance in 2027 (the year before patent loss) from $10.1B to $8.1B, with the decrement... More